Addressing the Digital Divide—mHealth in Cancer Care

Published Nov 8, 2017
Glasgow, Scotland, UK—8 November 2017—ISPOR, the professional society for health economics and outcomes research (HEOR), held an issue panel this afternoon that focused on mHealth in cancer care at its 20th Annual European Congress in Glasgow, Scotland, UK. The issue panel, “mHealth Among Clinicians and Patients in Cancer Care: How to Address the Digital Divide” [IP26], was moderated by Rosanna Tarricone, PhD, Bocconi University, Milan, Italy. Panelists included Maria Cucciniello, PhD, Bocconi University, Milan, Italy; Roma Maguire, PhD, MSc, University of Surrey, Glasgow, UK; and Nicola Scalzo, MSc, European Commission, Brussels, Belgium. The use of mobile technologies in health care—mHealth—is surging in cancer care; however, its potential has yet to be fully explored. The panel reviewed mHealth’s use in cancer care today, explored its potential, and discussed the barriers that currently prevent greater utilization. Maria Cucciniello, PhD discussed the results of an international survey on the use of mHealth that included the determinants that explain differences in uptake rates. Roma Maguire, PhD, MSc offered an overview of the potential mHealth has to empower patients and facilitate symptom management. Nicola Scalzo, MSc provided a regulatory perspective on mHealth and commented on how the newly adopted European Union regulation on medical devices may impact mHealth. Additional information on the ISPOR 20th Annual European Congress can be found here. Released presentations from the congress can be found here. Interested parties can follow news and developments from the congress on social media using the hashtag #ISPORGlasgow.

###

  ABOUT ISPOR ISPOR, the professional society for health economics and outcomes research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field. Web: www.ispor.org | LinkedIn: http://bit.ly/ISPOR-LIn | Twitter: http://bit.ly/ISPOR-T (@ISPORorg) | YouTube: http://bit.ly/ISPOR-YT | Facebook: http://bit.ly/ISPOR-FB

Related Stories

The Ozempic Paradox: How Spending Billions on Weight-Loss Drug Would Actually Reduce Overall Medicare Costs

Oct 14, 2025

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a landmark study by researchers at the University of Washington, Curta, Inc, and the University of North Carolina showing that broad Medicare coverage of semaglutide in diabetes, obesity, and liver disease could generate significant cost savings while delivering substantial health benefits to beneficiaries. The report, “Comprehensive Access to Semaglutide: Clinical and Economic Implications for Medicare,” was published in the October 2025 issue of Value in Health.

ISPOR Europe 2025 Plenaries and Speakers Announced

Oct 13, 2025

ISPOR announced details for its ISPOR Europe 2025. The conference is the leading global conference in Europe for health economics and outcomes research (HEOR) and is scheduled for 9-12 November in Glasglow, Scotland, UK with the theme, “Powering Value and Access Through Patient-Centered Collaboration.”
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×